Ferris Timothy G. 4
4 · Health Catalyst, Inc. · Filed Dec 29, 2020
Insider Transaction Report
Form 4
Ferris Timothy G.
Director
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2020-12-24−7,300→ 45,868 totalExercise: $11.78Exp: 2028-01-24→ Common Stock (7,300 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2020-12-28−5,501→ 40,367 totalExercise: $11.78Exp: 2028-01-24→ Common Stock (5,501 underlying) - Sale
Common Stock
2020-12-24$45.08/sh−7,300$329,107→ 5,443 total - Sale
Common Stock
2020-12-28$45.10/sh−5,501$248,113→ 5,443 total - Exercise/Conversion
Common Stock
2020-12-24$11.78/sh+7,300$85,994→ 12,743 total - Exercise/Conversion
Common Stock
2020-12-28$11.78/sh+5,501$64,802→ 10,944 total
Footnotes (4)
- [F1]The sales reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on June 12, 2020, in accordance with Rule 10b5-1.
- [F2]Represents the weighted average sale price of the shares sold ranging from $45.00 to $45.31 per share, inclusive.
- [F3]Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $45.00 to $45.53, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnotes (2) and (3).
- [F4]25% of the 62,500 shares underlying the options vested in an annual installment on January 24, 2019 and the remaining balance vested or will vest in equal monthly installments until the option vests in full on January 24, 2022.